周彩存, 林欢. EGFR 的突变异质性及在肺腺癌中对EGFR-TKI反应的不一致性[J]. 循证医学, 2013, 13(1): 46-49. DOI: 10.3969/j.issn.1671-5144.2013.01.008
    引用本文: 周彩存, 林欢. EGFR 的突变异质性及在肺腺癌中对EGFR-TKI反应的不一致性[J]. 循证医学, 2013, 13(1): 46-49. DOI: 10.3969/j.issn.1671-5144.2013.01.008
    ZHOU Cai-cun, LIN Huan. EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas[J]. Journal of Evidence-Based Medicine, 2013, 13(1): 46-49. DOI: 10.3969/j.issn.1671-5144.2013.01.008
    Citation: ZHOU Cai-cun, LIN Huan. EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas[J]. Journal of Evidence-Based Medicine, 2013, 13(1): 46-49. DOI: 10.3969/j.issn.1671-5144.2013.01.008

    EGFR 的突变异质性及在肺腺癌中对EGFR-TKI反应的不一致性

    EGFR Mutation Heterogeneity and the Mixed Response to EGFR Tyrosine Kinase Inhibitors of Lung Adenocarcinomas

    /

    返回文章
    返回